Dr Lalchandani Labs Limited (BOM:541299)
India · Delayed Price · Currency is INR 16.71
-0.87 (-4.95%)
At close: Feb 2, 2026
Dr Lalchandani Labs Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 43.79 | 44.54 | 48.1 | 50.4 | 112.79 | 97.8 |
Other Revenue | 0 | 0 | - | - | - | - |
| 43.8 | 44.54 | 48.1 | 50.4 | 112.79 | 97.8 | |
Revenue Growth (YoY) | 4.06% | -7.39% | -4.58% | -55.31% | 15.32% | 60.23% |
Cost of Revenue | 20.96 | 18.12 | 31.31 | 27.01 | 46.23 | 43.39 |
Gross Profit | 22.83 | 26.42 | 16.78 | 23.39 | 66.56 | 54.42 |
Selling, General & Admin | 3.19 | 3.19 | 3.15 | 6.95 | 15.28 | 8.24 |
Other Operating Expenses | 13.16 | 13.99 | 8.38 | 14.22 | 26.56 | 23.7 |
Operating Expenses | 22 | 22.82 | 20.7 | 29.12 | 47.72 | 37.09 |
Operating Income | 0.84 | 3.6 | -3.92 | -5.73 | 18.84 | 17.32 |
Interest Expense | -0.16 | -0.6 | -3.63 | -8.83 | -5.47 | -2.08 |
Interest & Investment Income | 0.05 | 0.05 | 0.17 | 0.05 | 0.01 | - |
Other Non Operating Income (Expenses) | 2.64 | -0.25 | -0.21 | -1.11 | -0.5 | -1.47 |
EBT Excluding Unusual Items | 3.37 | 2.79 | -7.58 | -15.62 | 12.87 | 13.77 |
Gain (Loss) on Sale of Assets | 0.02 | 0.02 | 1.88 | - | - | - |
Asset Writedown | -0 | -0 | -0.02 | -0.01 | - | - |
Other Unusual Items | 1.21 | 1.21 | 11.9 | - | - | - |
Pretax Income | 4.6 | 4.02 | 6.18 | -15.63 | 12.87 | 13.77 |
Income Tax Expense | -0.01 | -0.15 | - | - | 3.54 | 3.66 |
Net Income | 4.6 | 4.17 | 6.18 | -15.63 | 9.33 | 10.11 |
Net Income to Common | 4.6 | 4.17 | 6.18 | -15.63 | 9.33 | 10.11 |
Net Income Growth | -46.32% | -32.44% | - | - | -7.71% | 113.24% |
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 |
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 |
Shares Change (YoY) | 1.33% | 0.64% | -0.25% | -0.27% | 0.01% | -0.24% |
EPS (Basic) | 1.06 | 0.96 | 1.43 | -3.61 | 2.15 | 2.33 |
EPS (Diluted) | 1.06 | 0.96 | 1.43 | -3.61 | 2.15 | 2.33 |
EPS Growth | -47.02% | -32.87% | - | - | -7.72% | 113.76% |
Free Cash Flow | -3.02 | 2.12 | -3.33 | -3.04 | 9.1 | 9 |
Free Cash Flow Per Share | -0.69 | 0.49 | -0.77 | -0.70 | 2.10 | 2.07 |
Gross Margin | 52.14% | 59.33% | 34.89% | 46.41% | 59.01% | 55.64% |
Operating Margin | 1.91% | 8.09% | -8.14% | -11.36% | 16.70% | 17.71% |
Profit Margin | 10.51% | 9.37% | 12.84% | -31.01% | 8.28% | 10.34% |
Free Cash Flow Margin | -6.90% | 4.77% | -6.92% | -6.02% | 8.07% | 9.21% |
EBITDA | 6.01 | 8.78 | 2.33 | 0.91 | 24.72 | 22.48 |
EBITDA Margin | 13.73% | 19.72% | 4.84% | 1.80% | 21.91% | 22.98% |
D&A For EBITDA | 5.18 | 5.18 | 6.24 | 6.63 | 5.88 | 5.15 |
EBIT | 0.84 | 3.6 | -3.92 | -5.73 | 18.84 | 17.32 |
EBIT Margin | 1.91% | 8.09% | -8.14% | -11.36% | 16.70% | 17.71% |
Effective Tax Rate | - | - | - | - | 27.48% | 26.57% |
Revenue as Reported | 46.76 | 44.61 | 50.45 | 50.45 | 112.8 | 97.8 |
Advertising Expenses | - | 0.16 | 0.29 | 1.31 | 1.15 | 0.32 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.